Free Trial

Ionis Pharmaceuticals (IONS) SEC Filings & 10K Form

Ionis Pharmaceuticals logo
$36.02 -0.06 (-0.17%)
(As of 09:37 AM ET)

Recent Ionis Pharmaceuticals SEC Filings

DateFilerForm TypeView
12/20/2024
1:28 PM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
7:34 PM
BB BIOTECH AG (Filed by)
Ionis Pharmaceuticals (Subject)
Form SC 13G/A
11/13/2024
7:55 AM
Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144/A
11/08/2024
9:52 AM
Ionis Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
11/06/2024
3:06 PM
Ionis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
10:15 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
5:39 PM
Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2024
5:42 PM
Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
5:01 PM
Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2024
5:01 PM
Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
4:19 PM
Ionis Pharmaceuticals (Filer)
Form 424B5
09/09/2024
3:33 PM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
3:23 PM
Ionis Pharmaceuticals (Filer)
Form 424B5
09/04/2024
8:43 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:43 PM
Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:51 PM
Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:23 PM
Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144/A
09/04/2024
8:24 PM
Ionis Pharmaceuticals (Subject)
O'NEIL PATRICK R. (Reporting)
Form 144/A
09/04/2024
8:25 PM
HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144/A
09/04/2024
8:27 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144/A
09/04/2024
8:29 PM
Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144/A
09/04/2024
8:33 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4/A
09/04/2024
8:33 PM
Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144/A
09/04/2024
8:40 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:40 PM
Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:41 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:19 PM
Ionis Pharmaceuticals (Subject)
Swayze Eric (Reporting)
Form 144/A
09/04/2024
8:20 PM
Ionis Pharmaceuticals (Subject)
Schneider Eugene (Reporting)
Form 144/A
09/04/2024
8:21 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144/A
09/04/2024
8:02 PM
Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4/A
09/04/2024
8:06 PM
Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
Form 4/A
09/04/2024
8:11 PM
Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4/A
09/04/2024
8:13 PM
HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4/A
09/04/2024
7:51 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4/A
09/04/2024
7:52 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4/A
09/04/2024
7:42 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4/A
09/04/2024
7:42 PM
Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4/A
09/03/2024
6:18 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
4:27 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
2:35 PM
Ionis Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/01/2024
10:15 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
BITCOIN (Ad)

Did you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this...

07/17/2024
4:02 PM
BERTHELSEN SPENCER R (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
4:02 PM
Diaz Allene M. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
4:02 PM
HERMAN JOAN E (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
4:02 PM
Ionis Pharmaceuticals (Issuer)
KLEIN JOSEPH III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
4:03 PM
Ionis Pharmaceuticals (Issuer)
LOSCALZO JOSEPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
4:03 PM
Ionis Pharmaceuticals (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
4:03 PM
Ionis Pharmaceuticals (Issuer)
WENDER JOSEPH H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
3:11 PM
Diaz Allene M. (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2024
2:13 PM
Ionis Pharmaceuticals (Issuer)
YANG MICHAEL J. (Reporting)
Form 4/A
07/03/2024
1:48 PM
Ionis Pharmaceuticals (Issuer)
WENDER JOSEPH H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:48 PM
Ionis Pharmaceuticals (Issuer)
YANG MICHAEL J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:47 PM
BERTHELSEN SPENCER R (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:47 PM
Diaz Allene M. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:47 PM
Hayden Michael R (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:47 PM
HERMAN JOAN E (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:47 PM
Ionis Pharmaceuticals (Issuer)
KLEIN JOSEPH III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:47 PM
Ionis Pharmaceuticals (Issuer)
LOSCALZO JOSEPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:47 PM
Ionis Pharmaceuticals (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
4:52 PM
BERTHELSEN SPENCER R (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:29 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
9:59 AM
BERTHELSEN SPENCER R (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2024
3:33 PM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2024
6:15 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
4:25 PM
Ionis Pharmaceuticals (Issuer)
WENDER JOSEPH H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:55 PM
Ionis Pharmaceuticals (Issuer)
KLEIN JOSEPH III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
10:15 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
3:50 PM
Ionis Pharmaceuticals (Filer)
Form DEF 14A
04/25/2024
3:52 PM
Ionis Pharmaceuticals (Filer)
Form DEFA14A
04/25/2024
3:53 PM
Ionis Pharmaceuticals (Filer)
Form ARS
04/17/2024
4:16 PM
Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2024
4:19 PM
Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
7:59 PM
Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/16/2024
7:50 PM
Birchler Brian (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/08/2024
5:04 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
4:52 PM
Ionis Pharmaceuticals (Issuer)
Jenne Kyle (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/13/2024
4:52 PM
Ionis Pharmaceuticals (Issuer)
Jenne Kyle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:13 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:13 PM
Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:13 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:13 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:13 PM
Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
8:10 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
3:38 PM
Ionis Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/21/2024
10:17 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2024
9:39 AM
Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144/A
02/16/2024
6:47 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:34 PM
Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2024
5:09 AM
BB BIOTECH AG (Filed by)
Ionis Pharmaceuticals (Subject)
Form SC 13G/A
02/02/2024
6:54 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:54 PM
Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Has Trump Finally Gone Too Far? (Ad)

Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.

Register For The Webinar To Discover
02/02/2024
6:54 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:55 PM
HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:55 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:55 PM
Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:55 PM
Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:55 PM
Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
4:31 PM
Ionis Pharmaceuticals (Subject)
Swayze Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
4:34 PM
Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
4:21 PM
Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:IONS) was last updated on 12/26/2024 by MarketBeat.com Staff
From Our Partners